Project leads
Collaborators

Pathogenesis and therapy of KSHV-associated Malignancies

Mark Polizzotto

8 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Follow

Viyaja Sundararajan

University of Melbourne

Melbourne, Australia

Merrole Cole-Sinclair

University of Melbourne

Melbourne, Australia

Harold Tjalsma

Radboud University Nijmegen

Nijmegen, Netherlands

Zoe McQuilten

Monash University

Melbourne, Australia

John McNeil

Monash University

Melbourne, Australia

Erica Wood

Monash University

Melbourne, Australia

Ian Woolley

Monash University

Melbourne, Australia

Alfred Hospital

Melbourne, Australia

Christina Chang

Alfred Hospital

Melbourne, Australia

Mark Polizzotto

National Cancer Institute (NIH)

Rockville, United States

Related projects

Prashant Desai

Bridging KSHV Capsids to the Nuclear Egress Complex

Tyshia Kyree Gwin

Induction of tumor suppressor p16INK4A by human papillomavirus 16 E7 oncoprotein

Kenneth M Kaye

KSHV latent infection replication

Erle S Robertson

KSHV Genome Modification in KS Tissue

Jae U Jung

KSHV RTA: More than Viral Replication

Nancy Joan Raab-Traub

Herpesviral, Oncogenesis, Latency and Reactivation

Kenneth M Kaye

Genetic and Biochemical Studies of KSHV LANA

Eric Freed

U.S.-India Joint Working Group on the Prevention of Sexually Transmitted Diseases and HIV/AIDS via OAR Intramural to India grant

Shou-Jiang Gao

KSHV microRNAs in Cellular Transformation and Tumorigenesis